Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of sacubitril/valsartan on serum uric acid in hypertension with asymptomatic hyperuricemia
ChiCTR2100050320Phase 4Completed
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sacubitril + valsartan in essential hypertension and hyperuricemia (2 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoints: Change in serum uric acid and Blood pressure and heart rate. Started Sep 2021; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
essential hypertensionhyperuricemia
Beyond the preview
Go deeper on ChiCTR2100050320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050320.